Style | Citing Format |
---|---|
MLA | Goradel NH, et al.. "Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence." Toxicology and Applied Pharmacology, vol. 335, no. , 2017, pp. 56-63. |
APA | Goradel NH, Asghari MH, Moloudizargari M, Negahdari B, Haghiaminjan H, Abdollahi M (2017). Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence. Toxicology and Applied Pharmacology, 335(), 56-63. |
Chicago | Goradel NH, Asghari MH, Moloudizargari M, Negahdari B, Haghiaminjan H, Abdollahi M. "Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence." Toxicology and Applied Pharmacology 335, no. (2017): 56-63. |
Harvard | Goradel NH et al. (2017) 'Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence', Toxicology and Applied Pharmacology, 335(), pp. 56-63. |
Vancouver | Goradel NH, Asghari MH, Moloudizargari M, Negahdari B, Haghiaminjan H, Abdollahi M. Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence. Toxicology and Applied Pharmacology. 2017;335():56-63. |
BibTex | @article{ author = {Goradel NH and Asghari MH and Moloudizargari M and Negahdari B and Haghiaminjan H and Abdollahi M}, title = {Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence}, journal = {Toxicology and Applied Pharmacology}, volume = {335}, number = {}, pages = {56-63}, year = {2017} } |
RIS | TY - JOUR AU - Goradel NH AU - Asghari MH AU - Moloudizargari M AU - Negahdari B AU - Haghiaminjan H AU - Abdollahi M TI - Melatonin As an Angiogenesis Inhibitor to Combat Cancer: Mechanistic Evidence JO - Toxicology and Applied Pharmacology VL - 335 IS - SP - 56 EP - 63 PY - 2017 ER - |